Please assess the completion status of the following clinical trial:

Trial Title: Apogee International

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements;~* Enrollment into Apogee International will be comprised of newly enrolled, commercial use patients with the HeartWare HVAD System;~* Patient is consented prior to the HVAD implant procedure.~Exclusion Criteria:~* Patient who is, or is expected to be inaccessible for follow-up;~* Participation is excluded by local law;~* Patient is currently enrolled or plans to enroll in concurrent drug/device study that may confound the PSR results.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients implanted with HVAD System (Type: None): Patients intended to be implanted with a HeartWare HVAD per the current (local) guidelines, are eligible for enrollment into Apogee International and must be consented for Apogee International prior to the HVAD implant.

Based on this trial design, predict the completion outcome and termination type (if applicable).